Skip to content
Screener

Akebia Therapeutics AKBA Q1 2025 earnings

Reported May 8, 2025 · Before market open

Revenue$57.3MBeat by $6.5M
EPS$0.03Beat by $0.06
Revenue estimate$50.8M
EPS estimate-$0.03

Next report

Nov 9, 2026 (in 2 months)
Revenue estimate$46.9M
EPS estimate-$0.03

FAQ

When did Akebia Therapeutics report Q1 2025 earnings?
Akebia Therapeutics (AKBA) reported Q1 2025 earnings on May 8, 2025 before market open.
What were Akebia Therapeutics's Q1 2025 revenue and EPS?
Akebia Therapeutics reported revenue of $57.3M and eps of $0.03 for Q1 2025.
Did Akebia Therapeutics beat estimates in Q1 2025?
Revenue beat the consensus estimate of $50.8M by $6.5M. EPS beat the consensus estimate of $-0.03 by $0.06.
How did Akebia Therapeutics's Q1 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 75.8% from $32.6M a year earlier.
Where can I find Akebia Therapeutics's Q1 2025 SEC filings?
You can read the 8-K earnings release (0001517022-25-000027) and the 10-Q periodic report (0001628280-25-023460) directly on SEC EDGAR. The filing index links above go to sec.gov.